|
G |
Ache |
acetylcholinesterase |
decreases activity multiple interactions |
EXP ISO |
quinalphos results in decreased activity of ACHE protein Arsenic promotes the reaction [quinalphos results in decreased activity of ACHE protein]; quinalphos promotes the reaction [Arsenic results in decreased activity of ACHE protein] quinalphos metabolite results in decreased activity of ACHE protein; quinalphos results in decreased activity of ACHE protein |
CTD |
PMID:32270456 PMID:33844597 |
|
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
|
|
G |
Ahr |
aryl hydrocarbon receptor |
multiple interactions |
ISO |
quinalphos binds to and results in increased activity of AHR protein |
CTD |
PMID:18835618 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Alb |
albumin |
multiple interactions |
EXP |
[Arsenic co-treated with quinalphos] results in decreased expression of ALB protein |
CTD |
PMID:32270456 |
|
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Ar |
androgen receptor |
multiple interactions |
ISO |
Dihydrotestosterone inhibits the reaction [quinalphos results in increased activity of AR protein] |
CTD |
PMID:15064155 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Bche |
butyrylcholinesterase |
decreases activity multiple interactions |
ISO |
quinalphos results in decreased activity of BCHE protein pralidoxime inhibits the reaction [quinalphos results in decreased activity of BCHE protein] |
CTD |
PMID:24052565 |
|
NCBI chr 2:158,308,674...158,401,148
Ensembl chr 2:158,307,584...158,401,148
|
|
G |
Cat |
catalase |
multiple interactions decreases activity |
ISO EXP |
Plant Extracts inhibits the reaction [quinalphos results in decreased activity of CAT protein] [Arsenic co-treated with quinalphos] results in decreased activity of CAT protein |
CTD |
PMID:24581381 PMID:32270456 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
increases expression |
ISO |
quinalphos results in increased expression of CYP19A1 mRNA |
CTD |
PMID:34014595 |
|
NCBI chr 8:54,552,978...54,580,375
Ensembl chr 8:54,553,165...54,580,758
|
|
G |
Cyp26b1 |
cytochrome P450, family 26, subfamily b, polypeptide 1 |
decreases expression multiple interactions |
ISO |
quinalphos results in decreased expression of CYP26B1 mRNA Plant Extracts inhibits the reaction [quinalphos results in decreased expression of CYP26B1 mRNA] |
CTD |
PMID:24581381 |
|
NCBI chr 4:117,041,808...117,058,628
Ensembl chr 4:117,041,808...117,058,628
|
|
G |
Esr1 |
estrogen receptor 1 |
increases activity |
ISO |
quinalphos results in increased activity of ESR1 protein |
CTD |
PMID:15064155 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Esr2 |
estrogen receptor 2 |
increases activity |
ISO |
quinalphos results in increased activity of ESR2 protein |
CTD |
PMID:15064155 |
|
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
|
|
G |
G6pd |
glucose-6-phosphate dehydrogenase |
multiple interactions affects activity |
EXP |
[Monocrotophos co-treated with quinalphos] affects the activity of G6PD protein quinalphos affects the activity of G6PD protein |
CTD |
PMID:24248738 |
|
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
|
|
G |
Gsr |
glutathione-disulfide reductase |
multiple interactions affects activity decreases activity |
EXP |
[Arsenic co-treated with quinalphos] results in decreased activity of GSR protein; [Monocrotophos co-treated with quinalphos] affects the activity of GSR protein quinalphos affects the activity of GSR protein quinalphos results in decreased activity of GSR protein |
CTD |
PMID:24248738 PMID:32270456 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Hsd3b3 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 3 |
multiple interactions decreases expression |
ISO |
Plant Extracts inhibits the reaction [quinalphos results in decreased expression of HSD3B3 mRNA] |
CTD |
PMID:24581381 |
|
NCBI chr 2:186,138,044...186,144,024
Ensembl chr 2:186,138,044...186,144,033
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
multiple interactions |
ISO |
quinalphos binds to and results in increased activity of NR1I2 protein |
CTD |
PMID:21115097 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
G |
Star |
steroidogenic acute regulatory protein |
multiple interactions decreases expression |
ISO |
Plant Extracts inhibits the reaction [quinalphos results in decreased expression of STAR mRNA]; Plant Extracts inhibits the reaction [quinalphos results in decreased expression of STAR protein] quinalphos results in decreased expression of STAR mRNA; quinalphos results in decreased expression of STAR protein |
CTD |
PMID:24581381 |
|
NCBI chr16:66,267,094...66,274,368
Ensembl chr16:66,264,807...66,271,672
|
|
G |
Tp53 |
tumor protein p53 |
affects activity |
ISO |
quinalphos metabolite affects the activity of TP53 protein |
CTD |
PMID:35435491 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|